Cover Image
Market Research Report

Europe Genetic Testing Market (2019-2025)

Published by KBV Research Product code 911080
Published Content info 90 Pages
Delivery time: 1-2 business days
Price
Back to Top
Europe Genetic Testing Market (2019-2025)
Published: August 31, 2019 Content info: 90 Pages
Description

The Europe Genetic Testing Market would witness market growth of 10.8% CAGR during the forecast period (2019-2025).

In the past couple of decades, the market for genetic testing has witnessed rapid development. The growing technological developments have opened up several market expansion possibilities. The rise in chronic disease prevalence and the creation of customized test kits for niche therapeutic fields contribute to the accelerated market growth.

A wide variety of advantages provided by genetic testing, including an understanding of genetic changes in the fetus that may lead to unusual growth and improved knowledge of genetic diseases and disorders, contribute significantly to the growth of the market for genetic testing during the forecast period. Growing understanding of such conditions and disorders has led more individuals to go and test themselves and their family members to gain a stronger awareness of their genetic structure. This has resulted in a growing audience for genetic testing, expanding the market's growth chart to new stages. In addition, changes in food habits, pollution, and exposure to damaging chemicals radiation contribute to rising genetic disease incidence, accelerating the industry exponentially.

Based on Type, the market is segmented into Predictive and Presymptomatic Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Other Types. Based on Technology, the market is segmented into Cytogenetic Testing, Biochemical Testing and Molecular Testing. Based on Application, the market is segmented into Cancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis and Other Applications. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Myriad Genetics, Inc., Empire Genomics LLC, Bio-Rad Laboratories, Inc., Novartis AG, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Danaher Corporation, and Abbott Laboratories (Abbott Laboratories Molecular, Inc.).

Scope of the Study

Market Segmentation:

By Type

  • Predictive and Presymptomatic Carrier Testing
  • Prenatal and Newborn Testing
  • Diagnostic Testing
  • Pharmacogenomic Testing
  • Other Types

By Technology

  • Cytogenetic Testing
  • Biochemical Testing and
  • Molecular Testing

By Application

  • Cancer Diagnosis
  • Genetic Disease Diagnosis
  • Cardiovascular Disease Diagnosis and
  • Other Applications

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled:

  • Myriad Genetics, Inc.
  • Empire Genomics LLC
  • Bio-Rad Laboratories, Inc.
  • Novartis AG
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Qiagen N.V.
  • Illumina, Inc.
  • Danaher Corporation
  • Abbott Laboratories (Abbott Laboratories Molecular, Inc.)

Unique Offerings from KBV Research:

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Genetic Testing Market, by Type
    • 1.4.2 Europe Genetic Testing Market, by Technology
    • 1.4.3 Europe Genetic Testing Market, by Application
    • 1.4.4 Europe Genetic Testing Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Executive Summary
    • 2.1.3 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Europe Genetic Testing Market by Type

  • 3.1 Europe Predictive and Presymptomatic Testing Market by Country
  • 3.2 Europe Carrier Testing Market by Country
  • 3.3 Europe Prenatal and Newborn Testing Market by Country
  • 3.4 Europe Diagnostic Testing Market by Country
  • 3.5 Europe Pharmacogenomic Testing Market by Country
  • 3.6 Europe Other Types Genetic Testing Market by Country

Chapter 4. Europe Genetic Testing Market by Technology

  • 4.1 Europe Cytogenetic Testing Market by Country
  • 4.2 Europe Biochemical Testing Market by Country
  • 4.3 Europe Molecular Testing Market by Country

Chapter 5. Europe Genetic Testing Market by Application

  • 5.1 Europe Cancer Diagnosis Market by Country
  • 5.2 Europe Genetic Disease Diagnosis Market by Country
  • 5.3 Europe Cardiovascular Disease Diagnosis Market by Country
  • 5.4 Europe Other Applications Market by Country

Chapter 6. Europe Genetic Testing Market by Country

  • 6.1 Germany Genetic Testing Market
    • 6.1.1 Germany Genetic Testing Market by Type
    • 6.1.2 Germany Genetic Testing Market by Technology
    • 6.1.3 Germany Genetic Testing Market by Application
  • 6.2 UK Genetic Testing Market
    • 6.2.1 UK Genetic Testing Market by Type
    • 6.2.2 UK Genetic Testing Market by Technology
    • 6.2.3 UK Genetic Testing Market by Application
  • 6.3 France Genetic Testing Market
    • 6.3.1 France Genetic Testing Market by Type
    • 6.3.2 France Genetic Testing Market by Technology
    • 6.3.3 France Genetic Testing Market by Application
  • 6.4 Russia Genetic Testing Market
    • 6.4.1 Russia Genetic Testing Market by Type
    • 6.4.2 Russia Genetic Testing Market by Technology
    • 6.4.3 Russia Genetic Testing Market by Application
  • 6.5 Spain Genetic Testing Market
    • 6.5.1 Spain Genetic Testing Market by Type
    • 6.5.2 Spain Genetic Testing Market by Technology
    • 6.5.3 Spain Genetic Testing Market by Application
  • 6.6 Italy Genetic Testing Market
    • 6.6.1 Italy Genetic Testing Market by Type
    • 6.6.2 Italy Genetic Testing Market by Technology
    • 6.6.3 Italy Genetic Testing Market by Application
  • 6.7 Rest of Europe Genetic Testing Market
    • 6.7.1 Rest of Europe Genetic Testing Market by Type
    • 6.7.2 Rest of Europe Genetic Testing Market by Technology
    • 6.7.3 Rest of Europe Genetic Testing Market by Application

Chapter 7. Company Profiles

  • 7.1 Myriad Genetics, Inc.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental Analysis
    • 7.1.4 Research & Development Expense
    • 7.1.5 Recent strategies and developments:
      • 7.1.5.1 Product Launches:
      • 7.1.5.2 Collaborations, Partnerships and agreements:
  • 7.2 Empire Genomics LLC
    • 7.2.1 Company Overview
  • 7.3 Bio-Rad laboratories, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental and Regional Analysis
    • 7.3.4 Recent strategies and developments:
      • 7.3.4.1 Collaborations, partnerships and agreements:
      • 7.3.4.2 Product launches:
      • 7.3.4.3 Acquisition and mergers:
    • 7.3.5 Research & Development Expenses
  • 7.4 Novartis AG
    • 7.4.1 Company Overview
    • 7.4.1 Financial Analysis
    • 7.4.2 Segmental and Regional Analysis
    • 7.4.3 Research & Development Expense
    • 7.4.4 Recent strategies and developments:
      • 7.4.4.1 Collaborations, partnerships and agreements:
  • 7.5 Agilent Technologies, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Product launches:
      • 7.5.5.2 Expansions:
  • 7.6 Thermo Fischer Scientific, Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expense
    • 7.6.5 Recent strategies and developments:
      • 7.6.5.1 Collaborations, partnerships and agreements:
      • 7.6.5.2 Acquisition and mergers:
  • 7.7 Qiagen N.V.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Regional Analysis
    • 7.7.4 Research & Development Expense
    • 7.7.5 Recent strategies and developments:
      • 7.7.5.1 Product launches:
      • 7.7.5.2 Collaborations, partnerships and agreements:
  • 7.8 Illumina, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Regional Analysis
    • 7.8.4 Research & Development Expense
    • 7.8.5 Recent strategies and developments:
      • 7.8.5.1 Collaborations, partnerships and agreements:
      • 7.8.5.2 Product launches:
  • 7.9 Danaher Corporation
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental and Regional Analysis
    • 7.9.4 Research & Development Expense
    • 7.9.5 Recent strategies and developments:
      • 7.9.5.1 Acquisition and mergers:
  • 7.1 Abbott Laboratories (Abbott Laboratories Molecular, Inc.)
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Segmental and Regional Analysis
    • 7.10.4 Research & Development Expense
    • 7.10.5 Recent strategies and developments:
      • 7.10.5.1 Collaborations, partnerships and agreements:
      • 7.10.5.2 Product launches:

LIST OF TABLES

  • TABLE 1 EUROPE GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 2 EUROPE GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 3 EUROPE GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 4 EUROPE GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 5 EUROPE PREDICTIVE AND PRESYMPTOMATIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 6 EUROPE PREDICTIVE AND PRESYMPTOMATIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 7 EUROPE CARRIER TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 8 EUROPE CARRIER TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 9 EUROPE PRENATAL AND NEWBORN TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 10 EUROPE PRENATAL AND NEWBORN TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 11 EUROPE DIAGNOSTIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 12 EUROPE DIAGNOSTIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 13 EUROPE PHARMACOGENOMIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 14 EUROPE PHARMACOGENOMIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 15 EUROPE OTHER TYPES GENETIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 16 EUROPE OTHER TYPES GENETIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 17 EUROPE GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 18 EUROPE GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 19 EUROPE CYTOGENETIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 20 EUROPE CYTOGENETIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 21 EUROPE BIOCHEMICAL TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 22 EUROPE BIOCHEMICAL TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 23 EUROPE MOLECULAR TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 24 EUROPE MOLECULAR TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 25 EUROPE GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 26 EUROPE GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 27 EUROPE CANCER DIAGNOSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 28 EUROPE CANCER DIAGNOSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 29 EUROPE GENETIC DISEASE DIAGNOSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 30 EUROPE GENETIC DISEASE DIAGNOSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 31 EUROPE CARDIOVASCULAR DISEASE DIAGNOSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 32 EUROPE CARDIOVASCULAR DISEASE DIAGNOSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 33 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 34 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 35 EUROPE GENETIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 36 EUROPE GENETIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 37 GERMANY GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 38 GERMANY GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 39 GERMANY GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 40 GERMANY GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 41 GERMANY GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 42 GERMANY GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 43 GERMANY GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 44 GERMANY GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 45 UK GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 46 UK GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 47 UK GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 48 UK GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 49 UK GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 50 UK GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 51 UK GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 52 UK GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 53 FRANCE GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 54 FRANCE GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 55 FRANCE GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 56 FRANCE GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 57 FRANCE GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 58 FRANCE GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 59 FRANCE GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 60 FRANCE GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 61 RUSSIA GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 62 RUSSIA GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 63 RUSSIA GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 64 RUSSIA GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 65 RUSSIA GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 66 RUSSIA GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 67 RUSSIA GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 68 RUSSIA GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 69 SPAIN GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 70 SPAIN GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 71 SPAIN GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 72 SPAIN GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 73 SPAIN GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 74 SPAIN GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 75 SPAIN GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 76 SPAIN GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 77 ITALY GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 78 ITALY GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 79 ITALY GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 80 ITALY GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 81 ITALY GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 82 ITALY GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 83 ITALY GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 84 ITALY GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 85 REST OF EUROPE GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 86 REST OF EUROPE GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 87 REST OF EUROPE GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 88 REST OF EUROPE GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 89 REST OF EUROPE GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 90 REST OF EUROPE GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 91 REST OF EUROPE GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 92 REST OF EUROPE GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 93 KEY INFORMATION - MYRIAD GENETICS, INC.
  • TABLE 94 KEY INFORMATION - EMPIRE GENOMICS LLC
  • TABLE 95 KEY INFORMATION - BIO-RAD LABORATORIES, INC.
  • TABLE 96 KEY INFORMATION - NOVARTIS AG
  • TABLE 97 KEY INFORMATION - AGILENT TECHNOLOGIES, INC.
  • TABLE 98 KEY INFORMATION - THERMO FISHER SCIENTIFIC, INC.
  • TABLE 99 KEY INFORMATION - QIAGEN N.V.
  • TABLE 100 KEY INFORMATION - ILLUMINA, INC.
  • TABLE 101 KEY INFORMATION - DANAHER CORPORATION
  • TABLE 102 KEY INFORMATION - ABBOTT LABORATORIES

LIST OF FIGURES

  • FIG 1 METHODOLOGY FOR THE RESEARCH
Back to Top